General Information of Drug Transporter (DT)
DT ID DTD0385 Transporter Info
Gene Name SLC4A4
Transporter Name Electrogenic sodium bicarbonate cotransporter 1
Gene ID
8671
UniProt ID
Q9Y6R1
Post-Translational Modification of This DT
Overview ofSLC4A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Disulfide bond X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

167

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC4A4 Lysine 167 has the potential to affect its expression or activity.

Disulfide bond

  Cystine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

627

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC4A4 Cystine 627 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

629

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC4A4 Cystine 629 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC4A4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

674

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC4A4 Cystine 674 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC4A4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

686

Experimental Method

Co-Immunoprecipitation

Detailed Description

Disulfide bond (-SSR) at SLC4A4 Cystine 686 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

641

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC4A4 Asparagine 641 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

661

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC4A4 Asparagine 661 has the potential to affect its expression or activity.

Oxidation

  Cystine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

18

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC4A4 Cystine 18 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

433

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC4A4 Cystine 433 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC4A4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

443

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC4A4 Cystine 443 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC4A4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1036

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC4A4 Cystine 1036 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        40 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Regulating of the stoichiometry of the membrane transporter [5]

Role of PTM

Properties Modulation

Affected Drug/Substrate

Sodium and Bicarbonate

Results for Drug

Regulating the uptake of sodium and bicarbonate

Modified Residue

Serine

Modified Location

1026

Related Enzyme

cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1026 have been reported to cause a shift in the direction of basolateral membrane sodium bicarbonate transport from efflux to influx.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [6], [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

12

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 12 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

38

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 38 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC4A4 [6], [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

61

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 61 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC4A4 [6], [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

65

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 65 has the potential to affect its expression or activity.

  PTM Phenomenon6

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

68

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 68 has the potential to affect its expression or activity.

  PTM Phenomenon7

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

76

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 76 has the potential to affect its expression or activity.

  PTM Phenomenon8

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

77

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 77 has the potential to affect its expression or activity.

  PTM Phenomenon9

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

78

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 78 has the potential to affect its expression or activity.

  PTM Phenomenon10

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

79

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 79 has the potential to affect its expression or activity.

  PTM Phenomenon11

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

86

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 86 has the potential to affect its expression or activity.

  PTM Phenomenon12

Have the potential to influence SLC4A4 [12], [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

219

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 219 has the potential to affect its expression or activity.

  PTM Phenomenon13

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

223

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 223 has the potential to affect its expression or activity.

  PTM Phenomenon14

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

232

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 232 has the potential to affect its expression or activity.

  PTM Phenomenon15

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

233

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 233 has the potential to affect its expression or activity.

  PTM Phenomenon16

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

235

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 235 has the potential to affect its expression or activity.

  PTM Phenomenon17

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

245

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 245 has the potential to affect its expression or activity.

  PTM Phenomenon18

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

255

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 255 has the potential to affect its expression or activity.

  PTM Phenomenon19

Have the potential to influence SLC4A4 [10], [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 256 has the potential to affect its expression or activity.

  PTM Phenomenon20

Have the potential to influence SLC4A4 [10], [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

257

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 257 has the potential to affect its expression or activity.

  PTM Phenomenon21

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

262

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 262 has the potential to affect its expression or activity.

  PTM Phenomenon22

Have the potential to influence SLC4A4 [16]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

396

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 396 has the potential to affect its expression or activity.

  PTM Phenomenon23

Have the potential to influence SLC4A4 [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

399

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 399 has the potential to affect its expression or activity.

  PTM Phenomenon24

Have the potential to influence SLC4A4 [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

400

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 400 has the potential to affect its expression or activity.

  PTM Phenomenon25

Have the potential to influence SLC4A4 [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

543

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 543 has the potential to affect its expression or activity.

  PTM Phenomenon26

Have the potential to influence SLC4A4 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

675

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 675 has the potential to affect its expression or activity.

  PTM Phenomenon27

Have the potential to influence SLC4A4 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

696

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 696 has the potential to affect its expression or activity.

  PTM Phenomenon28

Have the potential to influence SLC4A4 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

706

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 706 has the potential to affect its expression or activity.

  PTM Phenomenon29

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

716

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 716 has the potential to affect its expression or activity.

  PTM Phenomenon30

Have the potential to influence SLC4A4 [13], [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

995

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 995 has the potential to affect its expression or activity.

  PTM Phenomenon31

Have the potential to influence SLC4A4 [13], [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1000

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1000 has the potential to affect its expression or activity.

  PTM Phenomenon32

Have the potential to influence SLC4A4 [6], [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1029

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1029 has the potential to affect its expression or activity.

  PTM Phenomenon33

Have the potential to influence SLC4A4 [6], [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1034

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1034 has the potential to affect its expression or activity.

  PTM Phenomenon34

Have the potential to influence SLC4A4 [20]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1039

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1039 has the potential to affect its expression or activity.

  PTM Phenomenon35

Have the potential to influence SLC4A4 [8], [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1044

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1044 has the potential to affect its expression or activity.

  PTM Phenomenon36

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1059

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1059 has the potential to affect its expression or activity.

  PTM Phenomenon37

Have the potential to influence SLC4A4 [8], [21]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1061

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1061 has the potential to affect its expression or activity.

  PTM Phenomenon38

Have the potential to influence SLC4A4 [6], [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1064

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1064 has the potential to affect its expression or activity.

  PTM Phenomenon39

Have the potential to influence SLC4A4 [6], [22]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1069

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1069 has the potential to affect its expression or activity.

  PTM Phenomenon40

Have the potential to influence SLC4A4 [23], [24]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1078

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Serine 1078 has the potential to affect its expression or activity.

  Threonine

        12 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [15], [25]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

49

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 49 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [26]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 163 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC4A4 [25], [27]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

207

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 207 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC4A4 [12], [28]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

230

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 230 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC4A4 [10], [29]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

239

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 239 has the potential to affect its expression or activity.

  PTM Phenomenon6

Have the potential to influence SLC4A4 [11], [29]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

249

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 249 has the potential to affect its expression or activity.

  PTM Phenomenon7

Have the potential to influence SLC4A4 [10], [15]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

254

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 254 has the potential to affect its expression or activity.

  PTM Phenomenon8

Have the potential to influence SLC4A4 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

693

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 693 has the potential to affect its expression or activity.

  PTM Phenomenon9

Have the potential to influence SLC4A4 [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

705

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 705 has the potential to affect its expression or activity.

  PTM Phenomenon10

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

715

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 715 has the potential to affect its expression or activity.

  PTM Phenomenon11

Have the potential to influence SLC4A4 [6], [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1071

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 1071 has the potential to affect its expression or activity.

  PTM Phenomenon12

Have the potential to influence SLC4A4 [23]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1077

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Threonine 1077 has the potential to affect its expression or activity.

  Tyrosine

          9 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

Have the potential to influence SLC4A4 [30], [31]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

30

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 30 has the potential to affect its expression or activity.

  PTM Phenomenon2

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 39 has the potential to affect its expression or activity.

  PTM Phenomenon3

Have the potential to influence SLC4A4 [6], [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

64

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 64 has the potential to affect its expression or activity.

  PTM Phenomenon4

Have the potential to influence SLC4A4 [27]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

206

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 206 has the potential to affect its expression or activity.

  PTM Phenomenon5

Have the potential to influence SLC4A4 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

677

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 677 has the potential to affect its expression or activity.

  PTM Phenomenon6

Have the potential to influence SLC4A4 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

704

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 704 has the potential to affect its expression or activity.

  PTM Phenomenon7

Have the potential to influence SLC4A4 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

718

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 718 has the potential to affect its expression or activity.

  PTM Phenomenon8

Have the potential to influence SLC4A4 [19]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

992

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 992 has the potential to affect its expression or activity.

  PTM Phenomenon9

Have the potential to influence SLC4A4 [12], [13]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1038

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A4 Tyrosine 1038 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon1

. [32]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

229

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC4A4 Lysine 229 has the potential to affect its expression or activity.
References
1 Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 2002 Jan;138(1):69-73.
2 iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: Q9Y6R1)
3 Interplay between disulfide bonding and N-glycosylation defines SLC4 Na+-coupled transporter extracellular topography. J Biol Chem. 2015 Feb 27;290(9):5391-404.
4 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5 Phosphorylation of Ser(982) in the sodium bicarbonate cotransporter kNBC1 shifts the HCO(3)(-) : Na(+) stoichiometry from 3 : 1 to 2 : 1 in murine proximal tubule cells. J Physiol. 2001 Dec 15;537(Pt 3):659-65.
6 Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
7 HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
8 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
9 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
10 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
12 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
13 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
14 Global Ion Suppression Limits the Potential of Mass Spectrometry Based Phosphoproteomics. J Proteome Res. 2019 Jan 4;18(1):493-507.
15 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
16 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
17 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
18 Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
19 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
20 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
21 Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
22 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
23 Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
24 Single-step enrichment by Ti4+-IMAC and label-free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution. Mol Cell Proteomics. 2014 Sep;13(9):2426-34.
25 Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
26 Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
27 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
28 Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction. J Proteomics. 2017 Aug 8;165:69-74.
29 Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells. PLoS One. 2018 Jul 12;13(7):e0199349.
30 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
31 Phosphoproteome resource for systems biology research. Methods Mol Biol. 2011;694:307-22.
32 ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins. Nucleic Acids Res. 2018;46(D1):D901-D910.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.